|
Status |
Public on Apr 21, 2014 |
Title |
Human BRAF-V600E melanoma cell lines drug sensitive vs drug resistant |
Organism |
Homo sapiens |
Experiment type |
Genome variation profiling by genome tiling array
|
Summary |
aCGH of human melanoma cell lines comparing parental (drug sensitve) vs isogenic drug resistant-derived subline
|
|
|
Overall design |
Two condition experiment: two BRAF-V600E mutant cell lines (drug sensitive - parental baseline) vs two derived sublines after chronic exposure to the MEK inhibitor trametinib (drug resistant) are compared
|
|
|
Contributor(s) |
Nathanson KL, Villanueva J, Wubbenhorst B |
Citation(s) |
24055054 |
|
Submission date |
Aug 01, 2013 |
Last update date |
Mar 21, 2017 |
Contact name |
Katherine Nathanson |
E-mail(s) |
knathans@exchange.upenn.edu
|
Organization name |
Perelman School of Medicine at the University of Pennsylvania
|
Street address |
421 Curie Blvd
|
City |
Philadelphia |
State/province |
PA |
ZIP/Postal code |
19103 |
Country |
USA |
|
|
Platforms (1) |
GPL9777 |
Agilent-021850 SurePrint G3 Human CGH Microarray (Feature Number version) |
|
Samples (4)
|
GSM1199178 |
BRAF-V600E melanoma_451Lu_parental_drug senstive |
GSM1199179 |
BRAF-V600E melanoma_451Lu_subline_drug resistant |
GSM1199180 |
BRAF-V600E melanoma_Mel1617_parental_drug senstive |
GSM1199181 |
BRAF-V600E melanoma_Mel1617_subline_drug resistant |
|
Relations |
BioProject |
PRJNA213902 |